Genomma Lab (Mexico) Insiders
| LABB Stock | MXN 14.58 0.48 3.40% |
Genomma Lab employs about 2.3 K people. The company is managed by 37 executives with a total tenure of roughly 165 years, averaging almost 4.0 years of service per executive, having 62.08 employees per reported executive. Break down of Genomma Lab's management performance can provide insight into the company performance.
| Maximo Juda CEO CEO, COO and Executive Vice-Pres |
| Jorge Valderrama CEO Chief Executive Officer |
Genomma |
Genomma Lab Management Team Effectiveness
The company has return on total asset (ROA) of 0.0921 % which means that it generated a profit of $0.0921 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1264 %, meaning that it generated $0.1264 on every $100 dollars invested by stockholders. Genomma Lab's management efficiency ratios could be used to measure how well Genomma Lab manages its routine affairs as well as how well it operates its assets and liabilities.Genomma Lab Workforce Comparison
Genomma Lab Internacional is currently regarded as number one stock in number of employees category among related companies. The total workforce of Health Care industry is now estimated at about 139,704. Genomma Lab claims roughly 2,297 in number of employees contributing just under 2% to equities under Health Care industry.
The company has Profit Margin (PM) of 0.08 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.2 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.2. Genomma Lab Internacional Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Genomma Lab Internacional Price Series Summation is a cross summation of Genomma Lab price series and its benchmark/peer.
Genomma Lab Notable Stakeholders
A Genomma Lab stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Genomma Lab often face trade-offs trying to please all of them. Genomma Lab's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Genomma Lab's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Maximo Juda | CEO, COO and Executive Vice-Pres | Profile | |
| Jorge Valderrama | Chief Executive Officer | Profile | |
| Rodrigo Aspra | Chairman of the Board, Independent Director | Profile | |
| Stefano Curti | Global President of Brands | Profile | |
| Ramon Sastre | Executive Vice President of Institutional Relations | Profile | |
| Alejandro Patino | Executive Vice President of Human Capital and Commercial Expansion | Profile | |
| Claudia Vettoretti | Vice-President of Marketing | Profile | |
| Antonio Galland | Executive Vice President, Chief Financial and Chief Administrative Officer | Profile | |
| Marco Sparvieri | Executive Vice-President of Global Sales | Profile | |
| Santiago Pelaez | Vice President of Industrial and Research and Development | Profile | |
| Juan Sparvieri | Chief Operating Officer, Vice President | Profile | |
| Renata Aspra | COO and Executive Vice-Pres | Profile | |
| Scott Emerson | Independent Director | Profile | |
| Marco Munoz | Non-Member Secretary of the Board of Directors | Profile | |
| Jorge Munoz | Independent Director | Profile | |
| Ignacio Rodriguez | Independent Director | Profile | |
| Leandro Gold | Independent Director | Profile | |
| Jose Fernandez | Independent Director | Profile | |
| Juan Gavito | Independent Director | Profile | |
| Luis MacKissack | Director | Profile | |
| Arturo Perez | Director | Profile | |
| Hector Gonzalez | Independent Director | Profile | |
| Javier Castilla | Independent Director | Profile | |
| Sabrina Aspra | Director of International Operations, Director | Profile | |
| Juan Alonso | Independent Director | Profile | |
| Roberto Sauma | Independent Director | Profile | |
| Cesar Lopez | Vice President of Global Marketing | Profile | |
| Efran Crdova | Deputy Sec | Profile | |
| Carlos Alonso | Independent Director | Profile | |
| Marianne Velasco | Global HR | Profile | |
| L Porres | Legal Officer | Profile | |
| Burkhard Wittek | Director | Profile | |
| Alejandro Patio | Media, Relations | Profile | |
| Engineer Galland | Exec CFO | Profile | |
| Mximo Juda | Advisor | Profile | |
| Daniel Neria | Head Relations | Profile | |
| Leticia Herrera | Global Director of Human Resources (Genomma Experience) | Profile |
About Genomma Lab Management Performance
The success or failure of an entity such as Genomma Lab Internacional often depends on how effective the management is. Genomma Lab management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Genomma management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Genomma management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Genomma Lab Internacional, S.A.B. de C.V. together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico, the United States, and Latin America. Genomma Lab Internacional, S.A.B. de C.V. was founded in 1996 and is based in Mexico City, Mexico. GENOMMA LAB operates under Drug ManufacturersSpecialty Generic classification in Mexico and is traded on Mexico Stock Exchange. It employs 1451 people.
The data published in Genomma Lab's official financial statements usually reflect Genomma Lab's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Genomma Lab Internacional. For example, before you start analyzing numbers published by Genomma accountants, it's critical to develop an understanding of what Genomma Lab's liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Genomma Lab's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Genomma Lab's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Genomma Lab's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Genomma Lab Internacional. Please utilize our Beneish M Score to check the likelihood of Genomma Lab's management manipulating its earnings.
Genomma Lab Workforce Analysis
Traditionally, organizations such as Genomma Lab use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Genomma Lab within its industry.Genomma Lab Manpower Efficiency
Return on Genomma Lab Manpower
| Revenue Per Employee | 6.7M | |
| Revenue Per Executive | 418.6M | |
| Net Income Per Employee | 569.4K | |
| Net Income Per Executive | 35.3M |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Genomma Lab Internacional. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Complementary Tools for Genomma Stock analysis
When running Genomma Lab's price analysis, check to measure Genomma Lab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genomma Lab is operating at the current time. Most of Genomma Lab's value examination focuses on studying past and present price action to predict the probability of Genomma Lab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genomma Lab's price. Additionally, you may evaluate how the addition of Genomma Lab to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |